Infrastructure Buildouts and Capital Maneuvers Dominate a Mixed Bag of EquitiesGlobal Report·10 hours agoNVT-7.10%UCTT-6.90%
Precious Metals ETFs See Inflow Surge Amid Broad Market RotationGlobal Report·Aug 15 at 05:12 AMCGTX-3.74%
Macro Headwinds and AI Divergence: The Repricing of US Cloud and Growth StocksGlobal Report·Aug 7 at 04:18 AMADSK+2.13%HUBS+5.14%
Cognition Therapeutics (CGTX) to Post Quarterly Earnings on ThursdayMarket Beat·Jul 30 at 05:26 AMCGTX-3.74%
The Fringes of Wall Street: How Small-Cap Innovators and Niche Bets Are Navigating 2026Global Report·Jul 30 at 04:13 AMCERT+0.13%BLNK-3.78%
US Equities Tracker: Restructuring and Pipeline Milestones Shape H2 2026Global Report·Jul 22 at 04:18 AMSFM-2.18%CGTX-3.74%
The Unbundling of the Long Tail: Structural Realities at the Edges of the Value ChainGlobal Report·Jul 21 at 04:13 AMNUE-3.11%BTG-4.23%
Cognition Therapeutics posts press release on B. Riley summit fireside chat to IR websitePUBT·Jul 13 at 06:31 AMCGTX-3.74%
Hippo deploys Cognition’s Devin AI software engineer across insurance operationsPUBT·Jun 25 at 08:02 AMHIPO+0.95%CGTX-3.74%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jun 24 at 12:05 PMATLN0.00%PLSM-0.69%
Cognition Therapeutics targets mid-2027 start for Phase 3 zervimesine trial in DLB psychosisPUBT·Jun 24 at 06:30 AMCGTX-3.74%
